Le Lézard
Classified in: Health
Subjects: STP, AVO

Statement of Cathy Bennett, NJHA President and CEO, on Gov. Murphy's 2019 State Budget Proposal


PRINCETON, N.J., March 13, 2018 /PRNewswire-USNewswire/ -- "We appreciate Gov. Murphy's focus on good health by continuing critical funding for key healthcare initiatives. It's vitally important that we maintain charity care funding for the underserved in all communities; graduate medical education to support the graduates of New Jersey's medical schools who are the next generation of healthcare professionals; incentive programs that promote safe, quality healthcare; and care for our most frail individuals in nursing homes.

"But good health is not just clinical care ? now more than ever it's about what's occurring in our communities. We applaud the Governor's commitment of $100 million to fight the state's opioid crisis and additional budget items that support good health not just in our facilities but in the communities where we live, work and play. We look forward to working with Gov. Murphy, his Administration and the Legislature to turn these budget priorities into actions that improve the health of the people of New Jersey."

SOURCE New Jersey Hospital Association (NJHA)


These press releases may also interest you

at 05:25
PureTech Announces Annual Results for Year Ended December 31, 2023
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
Aquaporin raises DKK 172 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance HealthCare Group expands luxury mental health and addiction services for UHNW individuals
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions and The Pathway join forces to elevate continuing education in restorative dentistry.
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

More news about Health...


News published on and distributed by: